Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Galmed Pharmaceuticals Ltd. buy Barclays PLC

Start price
€0.26
08.08.24 / 50%
Target price
€85.19
08.08.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.08.25. The prediction end date can be changed by Barclays_PLC at any time.
Performance without dividends (%)
Name 1w
Galmed Pharmaceuticals Ltd. -
iShares Core DAX® -1.941%
iShares Nasdaq 100 -3.642%
iShares Nikkei 225® -2.728%
iShares S&P 500 -3.440%

Comments by Barclays_PLC for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 85.188
Change
Ends at 08.08.25

Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $85.00 to $93.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat

Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.40
09.05.24
€78.88
09.05.25
-34.34%
07.08.24